96 related articles for article (PubMed ID: 1532544)
1. Cilazapril and early atherosclerotic changes after balloon injury of porcine carotid arteries.
Lam JY; Lacoste L; Bourassa MG
Circulation; 1992 Apr; 85(4):1542-7. PubMed ID: 1532544
[TBL] [Abstract][Full Text] [Related]
2. Prevention of neointima formation by mibefradil after vascular injury in rats: comparison with ACE inhibition.
Schmitt R; Clozel JP; Iberg N; Bühler FR
Cardiovasc Drugs Ther; 1996 May; 10(2):101-5. PubMed ID: 8842500
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of inhibition of neointimal formation by the angiotensin-converting enzyme inhibitor cilazapril. A study in balloon catheter-injured rat carotid arteries.
Fingerle J; Müller RM; Kuhn H; Pech M; Baumgartner HR
Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1945-50. PubMed ID: 7583575
[TBL] [Abstract][Full Text] [Related]
4. Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon.
Hanson SR; Powell JS; Dodson T; Lumsden A; Kelly AB; Anderson JS; Clowes AW; Harker LA
Hypertension; 1991 Oct; 18(4 Suppl):II70-6. PubMed ID: 1833327
[TBL] [Abstract][Full Text] [Related]
5. Suppression of the vascular response to injury: the role of angiotensin-converting enzyme inhibitors.
Powell JS; Muller RK; Baumgartner HR
J Am Coll Cardiol; 1991 May; 17(6 Suppl B):137B-142B. PubMed ID: 1826694
[TBL] [Abstract][Full Text] [Related]
6. Intramural methotrexate therapy for the prevention of neointimal thickening after balloon angioplasty.
Muller DW; Topol EJ; Abrams GD; Gallagher KP; Ellis SG
J Am Coll Cardiol; 1992 Aug; 20(2):460-6. PubMed ID: 1386089
[TBL] [Abstract][Full Text] [Related]
7. The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition.
Powell JS; Müller RK; Rouge M; Kuhn H; Hefti F; Baumgartner HR
J Cardiovasc Pharmacol; 1990; 16 Suppl 4():S42-9. PubMed ID: 1705627
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury.
Powell JS; Clozel JP; Müller RK; Kuhn H; Hefti F; Hosang M; Baumgartner HR
Science; 1989 Jul; 245(4914):186-8. PubMed ID: 2526370
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibitor cilazapril suppresses expression of basic fibroblast growth factor messenger ribonucleic acid and protein in endothelial and intimal smooth muscle cells in a vascular injury model of spontaneous hypertensive rats.
Iwata A; Masago A; Yamada K
Neurol Med Chir (Tokyo); 1998 May; 38(5):257-64; discussion 264-5. PubMed ID: 9640960
[TBL] [Abstract][Full Text] [Related]
10. Spirapril and cilazapril inhibit neointimal lesion development but cause no detectable inhibition of lumen narrowing after carotid artery balloon catheter injury in the rat.
Cook NS; Zerwes HG; Pally C; Rudin M; Hof RP
Blood Press; 1993 Dec; 2(4):322-31. PubMed ID: 8173703
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of converting enzyme and neointima formation after vascular injury in rabbits and guinea pigs.
Clozel JP; Hess P; Michael C; Schietinger K; Baumgartner HR
Hypertension; 1991 Oct; 18(4 Suppl):II55-9. PubMed ID: 1833324
[TBL] [Abstract][Full Text] [Related]
12. Vascular protection with cilazapril.
Clozel JP; Powell JS; Kuhn H; Müller RK; Hefti F; Baumgartner HR
Drugs; 1991; 41 Suppl 1():62-7. PubMed ID: 1712274
[TBL] [Abstract][Full Text] [Related]
13. Human urine kininogenase attenuates balloon-induced intimal hyperplasia in rabbit carotid artery through transforming growth factor β1/Smad2/3 signaling pathway.
Lan W; Yang F; Li Z; Liu L; Sang H; Jiang Y; Xiong Y; Zhang R
J Vasc Surg; 2016 Oct; 64(4):1074-83. PubMed ID: 26054589
[TBL] [Abstract][Full Text] [Related]
14. Influence of the status of the renin-angiotensin system on the effect of cilazapril on neointima formation after vascular injury in rats.
Clozel JP; Müller RK; Roux S; Fischli W; Baumgartner HR
Circulation; 1993 Sep; 88(3):1222-7. PubMed ID: 8353884
[TBL] [Abstract][Full Text] [Related]
15. A dilemma for the 1990s. Choosing appropriate experimental animal model for the prevention of restenosis.
Ferrell M; Fuster V; Gold HK; Chesebro JH
Circulation; 1992 Apr; 85(4):1630-1. PubMed ID: 1532546
[No Abstract] [Full Text] [Related]
16. Decreased lumen size after balloon injury despite inhibition of neointimal thickening and antivasospastic treatment.
Cook NS; Zerwes HG; Pally C; Rudin M; Hof RP
Cardiovasc Res; 1994 Feb; 28(2):215-20. PubMed ID: 8143303
[TBL] [Abstract][Full Text] [Related]
17. Cilazapril suppresses myointimal proliferation after vascular injury: effects on growth factor induction in vascular smooth muscle cells.
Powell JS; Rouge M; Müller RK; Baumgartner HR
Basic Res Cardiol; 1991; 86 Suppl 1():65-74. PubMed ID: 1827985
[TBL] [Abstract][Full Text] [Related]
18. Selective antagonism of the ET(A) receptor reduces neointimal hyperplasia after balloon-induced vascular injury in pigs.
Burke SE; Lubbers NL; Gagne GD; Wessale JL; Dayton BD; Wegner CD; Opgenorth TJ
J Cardiovasc Pharmacol; 1997 Jul; 30(1):33-41. PubMed ID: 9268219
[TBL] [Abstract][Full Text] [Related]
19. Heparin and cilazapril together inhibit injury-induced intimal hyperplasia.
Clowes AW; Clowes MM; Vergel SC; Müller RK; Powell JS; Hefti F; Baumgartner HR
Hypertension; 1991 Oct; 18(4 Suppl):II65-9. PubMed ID: 1833326
[TBL] [Abstract][Full Text] [Related]
20. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
Circulation; 1992 Jul; 86(1):100-10. PubMed ID: 1535568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
